Drug · DIN 02246793
SPIRIVA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 21, 2002; first marketed November 21, 2002.
- Drug Identification Number (DIN)
- 02246793
- Company (DIN owner)
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Inhalation
- Therapeutic class (ATC)
- Tiotropium bromide R03BB04
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE) | 18 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 20, 2002: NOC 803New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “spiriva”. A notice may cover another product or only some lots: read it to see what it covers.
- Spiriva Capsules ; Out-of-specification (uniformity of delivered dose)June 25, 2026 · Drugs · Product quality · Type III
- Spiriva (2013-10-07)July 25, 2014 · Drugs · Product safety · Type III